A detailed history of Sector Gamma As transactions in Alkermes Plc. stock. As of the latest transaction made, Sector Gamma As holds 100,000 shares of ALKS stock, worth $2.81 Million. This represents 0.9% of its overall portfolio holdings.

Number of Shares
100,000
Previous 194,000 48.45%
Holding current value
$2.81 Million
Previous $4.68 Million 40.13%
% of portfolio
0.9%
Previous 1.83%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$23.01 - $28.55 $2.16 Million - $2.68 Million
-94,000 Reduced 48.45%
100,000 $2.8 Million
Q2 2024

Aug 09, 2024

SELL
$23.21 - $27.24 $1.35 Million - $1.59 Million
-58,319 Reduced 23.11%
194,000 $4.68 Million
Q1 2024

May 08, 2024

BUY
$26.4 - $32.56 $1.38 Million - $1.7 Million
52,319 Added 26.16%
252,319 $6.83 Million
Q4 2023

Feb 05, 2024

BUY
$23.37 - $28.68 $4.67 Million - $5.74 Million
200,000 New
200,000 $5.55 Million

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.61B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Sector Gamma As Portfolio

Follow Sector Gamma As and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sector Gamma As, based on Form 13F filings with the SEC.

News

Stay updated on Sector Gamma As with notifications on news.